Parameter | Group A(127 cases) | Group B(112 cases) | P |
---|---|---|---|
General conditions | |||
Age(years) | 60.27 ± 9.78 | 59.88 ± 9.49 | 0.832# |
Sex (male/female) | 78/49 | 61/51 | 0.277* |
BMI(kg/m2) | 22.58 ± 2.91 | 24.28 ± 3.45 | 0.083# |
ASA(n,I/II/III/IV) | 2/101/23/1 | 0/94/18/0 | 0.402* |
Initial symptoms [n (%)] | |||
Jaundice | 74(58.27%) | 67(59.82%) | 0.807* |
Abdominal pain | 54(42.51%) | 49(43.75%) | 0.848* |
Fever | 12(9.44%) | 4(3.57%) | 0.070* |
Comorbidities [n (%)] | |||
CHD | 7(5.51%) | 10(8.92%) | 0.305* |
HBP | 39(30.70%) | 40(35.71%) | 0.412* |
DM | 20(15.75%) | 16(14.28%) | 0.752* |
Pancreatitis history | 4(3.15%) | 7(6.25%) | 0.254* |
Hepatitis | 8(6.30%) | 8(7.14%) | 0.928* |
Opearation history | 13(10.24%) | 15(13.39%) | 0.449* |
Blood tests | |||
CA199(U/mL)a | 94.50 | 68.50 | 0.315+ |
CA125(U/mL)a | 12.90 | 14.70 | 0.323+ |
Direct bilirubin(mmol/L)a | 60.00 | 64.00 | 0.773+ |
Preoperative treatments [n (%)] | |||
Preoperative PTCD | 46(36.22%) | 36(32.14%) | 0.508* |
Preoperative ENBD | 17(13.38%) | 13(11.60%) | 0.679* |